Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma

被引:21
作者
Serrano, Maria F.
Katz, Matthew [2 ]
Yan, Yan [2 ]
Kibel, Adam S. [2 ]
Humphrey, Peter A. [1 ,2 ]
机构
[1] Washington Univ, Med Ctr, Dept Pathol & Immunol, Div Anat & Mol Pathol,Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg, Div Urol Surg, St Louis, MO 63110 USA
关键词
kidney; neoplasm; grade; stage; survival;
D O I
10.1002/cncr.23574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The prognostic value of Fuhrman nuclear grade for patients with renal cell carcinoma has been well-characterized. However, to the authors' knowledge, the prognostic significance of the amount of high-grade renal cell carcinoma has not been previously analyzed. METHODS, The authors identified 898 consecutive renal cell carcinoma cases treated with nephrectomy between 1989 and 2003. Histopathologic features that were captured based on re-review of all slides included histologic type, pathologic stage, conventional Fuhrman grade, and percentage of Fuhrman grade 3 and 4 carcinoma, as ascertained by visual inspection of histologic slides. The clinical endpoints were metastasis-free survival, cancer-specific survival, and overall survival. RESULTS. Kaplan-Meier analysis demonstrated that both conventional Fuhrman grading and the percentage of Fuhrman grade 3 and 4 carcinoma were highly correlated with all 3 measures of patient survival (P < .0001). The creation of 3 categories of the percentage of Fuhrman grade 3 and 4 carcinoma (0%, 1-50%, and 51-100%) generated distinctly separate survival curves. On Cox proportional hazards multivariate analysis, TNM stage, tumor size, and the percentage of Fuhrman grade 3 and 4 carcinoma were all found to be significantly associated with all 3 types of patient survival (all P values < .05). CONCLUSIONS. The determination of the percentage of renal cell carcinoma that is 0%, 1% to 50%, or 51% to 100% high Fuhrman grade 3 and 4 is a simple and powerful measurement of patient outcome after surgery that provides additional prognostic information beyond stage, tumor size, and conventional Fuhrman grade. This prognostic information could be useful in the stratification of patients into prognostic groups for the development of more individualized follow-up schedules and for enrollment into clinical trials.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 50 条
  • [41] Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma
    Fukushima, Hiroshi
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Tobisu, Ken-ichi
    Koga, Fumitaka
    JOURNAL OF UROLOGY, 2016, 195 (01) : 26 - 32
  • [42] Survival in patients with rare subtypes of renal cell carcinoma
    Grabowski, M
    Huzarski, T
    Lubinski, J
    Sikorski, A
    BJU INTERNATIONAL, 2002, 89 (06) : 599 - 600
  • [43] Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma
    Carreta Ruano, Anna Paula
    Gadelha Guimaraes, Andrea Paiva
    Braun, Alexcia C.
    Flores, Bianca C. T. C. P.
    Shizue Tariki, Milena
    Abdallah, Emne A.
    Aparecida Torres, Jacqueline
    Noronha Nunes, Diana
    Tirapelli, Bruna
    Cordeiro de Lima, Vladmir C.
    Ferretti Fanelli, Marcello
    Colombo, Pierre-Emmanuel
    Anastacio da Costa, Alexandre Andre Balieiro
    Alix-Panabieres, Catherine
    Domingos Chinen, Ludmilla Thome
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [44] Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: A comparison with conventional renal cell carcinoma
    Ku, Ja Hyeon
    Moon, Kyung Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (05) : 487 - 491
  • [45] Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis
    Xie, Yongpeng
    Chen, Luyao
    Ma, Xin
    Li, Hongzhao
    Gu, Liangyou
    Gao, Yu
    Fan, Yang
    Zhang, Yu
    Zhang, Xu
    SCIENTIFIC REPORTS, 2017, 7
  • [46] Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population-level analysis of 2400 patients
    Chen, Michelle M.
    Roman, Sanziana A.
    Sosa, Julie A.
    Judson, Benjamin L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (02): : 158 - 163
  • [47] Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy
    Katayama, Satoshi
    Pradere, Benjamin
    Grossman, Nico C.
    Potretzke, Aaron M.
    Boorjian, Stephen A.
    Ghoreifi, Alireza
    Daneshmand, Sia
    Djaladat, Hooman
    Sfakianos, John P.
    Mari, Andrea
    Khene, Zine-Eddine
    D'Andrea, David
    Hayakawa, Nozomi
    Breda, Alberto
    Fontana, Matteo
    Fujita, Kazutoshi
    Antonelli, Alessandro
    van Doeveren, Thomas
    Steinbach, Christina
    Mori, Keiichiro
    Laukhtina, Ekaterina
    Roupret, Morgan
    Margulis, Vitaly
    Karakiewicz, Pierre, I
    Araki, Motoo
    Comperat, Eva
    Nasu, Yasutomo
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (01) : 63 - 69
  • [48] Establishment of prognostic nomogram for high-grade parotid gland mucoepidermoid carcinoma based on the SEER database
    Wu, Yubin
    Wu, Shihai
    Li, Xianming
    ENT-EAR NOSE & THROAT JOURNAL, 2022, : NP75 - NP84
  • [49] Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma
    Siamakpour-Reihani, Sharareh
    Owzar, Kouros
    Jiang, Chen
    Turner, Taylor
    Deng, Yiwen
    Bean, Sarah M.
    Horton, Janet K.
    Berchuck, Andrew
    Marks, Jeffrey R.
    Dewhirst, Mark W.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 23 - 29
  • [50] Survival outcomes of patients with high-grade and poorly differentiated thymic neuroendocrine carcinoma
    Hamaji, Masatsugu
    Omasa, Mitsugu
    Nakagawa, Tatsuo
    Miyahara, So
    Suga, Michiharu
    Kawakami, Kenzo
    Aoyama, Akihiro
    Date, Hiroshi
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 31 (01) : 98 - 101